WHAT SETS US APART
Study Startup
Contract / Budget Timelines
- Fast-track
- Reviewed within 1 week
Accelerated Start-Up Timeline
- Regulatory edits within 1 week
- Study start-up done during budget edits
Recruitment / Retention
- 14 clinics
- >20,000 patients per month
- Developed database
- In-house marketing
- Low Screen-fail rate (<11%)
- Prescreening team
- Complimentary prescreening visits with a Sub-Investigator
- Spanish speaking staff
Community Engagement
- Pediatric providers
- Rheumatology partnership
- Community events
- Informational dinners
- Podcast appearances
Quality Assurance
- Dedicated Quality assurance/Data entry staff
- 48-hour data entry/query resolution target
- Quarterly in-house mock audits
Experienced Site Staff
- CCRC
- GCP certified
- IATTA certified
- Members of SCRS, ACRP and SOCRA
Current Studies
Status: RECRUITING
- Adult Participants with hair loss affecting >50% of the scalp
- Amlitelimab monotherapy by subcutaneous injection (placebo-controlled)
If you are interested in participating, please click the gold ‘PARTCIPATE NOW’ button above.
You may also email research@apexskin.com or call us at 440-940-2739
Status: RECRUITING
- Adult participants with moderate-to-severe atopic dermatitis (eczema)
- Subcutaneous injection (placebo-controlled)
If you are interested in participating, please click the gold ‘PARTCIPATE NOW’ button above.
You may also email research@apexskin.com or call us at 440-940-2739
Status: RECRUITING in Canton and Mayfield Heights
- A study of Patidegib Gel 2% for the reduction of disease burden of persistently developing basal cell carcinomas in subjects with Gorlin Syndrome (placebo-controlled)
If you are interested in participating, please click the gold ‘PARTCIPATE NOW’ button above.
You may also email research@apexskin.com or call us at 440-940-2739
Status: RECRUITING
- IV Infusion of Vilobelimab for Ulcerative Pyoderma Gangrenosum (placebo-controlled)
If you are interested in participating, please click the gold ‘PARTCIPATE NOW’ button above.
You may also email research@apexskin.com or call us at 440-940-2739
Status: RECRUITING
- Subcutaneous injection for adult patients with moderate to severe hidradenitis suppurativa
- Placebo controlled for the first 16-weeks of treatment
- Possibility of receiving open label treatment for an additional 3-years
If you are interested in participating, please click the gold ‘PARTCIPATE NOW’ button above.
You may also email research@apexskin.com or call us at 440-940-2739
Status: RECRUITING
- Oral treatment for patients with moderate-to-severe Plaque Psoriasis (placebo-controlled)
If you are interested in participating, please click the gold ‘PARTCIPATE NOW’ button above.
You may also email research@apexskin.com or call us at 440-940-2739
Status: RECRUITING
- Chronic Spontaneous Urticaria
- Subcutaneous injection of Barzolvolimab (placebo-controlled)
If you are interested in participating, please click the gold ‘PARTCIPATE NOW’ button above.
You may also email research@apexskin.com or call us at 440-940-2739
Our main research center is inside our new, state-of-the art, medical building in Mayfield Heights, OH.
We have approximately 2,000 square feet of space dedicated to research.
Facility
- Ambient
- 2-8 degree C refrigerators
- -20 degree C freezer
- -70 degree C freezer
Refrigerated and ambient centrifuge
Dry ice storage
ECG
Annually calibrated vital monitoring equipment
Emergency medicine kit including epinephrine and an AED
Onsite pharmacy
Onsite Laboratory
3+ private patient rooms
Locked storage
Private monitoring space
Research Experience
- Atopic Dermatitis (Eczema) for adults and children
- Psoriasis for adults and children (various locations)
- Hidradenitis Suppurativa
- Gorlin Syndrome
- Pyoderma Gangrenosum
- Lichen Planus
- Vitiligo
- Prurigo Nodularis
- Alopecia
- Basal and Squamous Cell Carcinoma
- Seborrheic Keratosis